Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer.

Thomas Benjamin KarasicMark H O'HaraUrsina R TeitelbaumNevena DamjanovBruce J GiantonioTracy S d'EntremontMaryann GallagherPaul J ZhangPeter J O'Dwyer

Published in: The oncologist (2020)

Palbociclib has limited single-agent activity in gastroesophageal tumors.

Keyphrases

metastatic breast cancer
open label
placebo controlled